phenoxybenzamine has been researched along with Heart Disease, Ischemic in 4 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugge, E | 1 |
| Ytrehus, K | 1 |
| Tsuchida, A | 1 |
| Liu, Y | 1 |
| Liu, GS | 1 |
| Cohen, MV | 2 |
| Downey, JM | 2 |
| Walsh, RS | 1 |
| Goto, M | 1 |
| Sakakibara, Y | 1 |
4 other studies available for phenoxybenzamine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
Topics: Alkaloids; Animals; Benzophenanthridines; In Vitro Techniques; Male; Myocardial Infarction; Myocardi | 1995 |
alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals | 1994 |
Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release.
Topics: Adenosine; Adrenergic alpha-Antagonists; Animals; Catecholamines; Heart; Hemodynamics; Hypoxia; In V | 1995 |
Maldistribution of multidose blood cardioplegia: pharmacologic intervention to prevent subendocardial hypoperfusion by alpha-adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Cardioplegic Solutions; Coronary Vessels | 1997 |